On Saturday April 17th 2004, the Netherlands Centre for Doping Affairs (NeCeDo) and the World Anti-Doping Agency (WADA) have organized the “Gene Doping” workshop during the 38th annual meeting of the European Society for Clinical Investigation (ESCI) in Utrecht, the Netherlands.

A short summary of the presentations can be found here.

The full report of the research done by the Netherlands centre for doping affairs on gene doping can be seen here.
 


11.15 - 11.30 Introduction by Rens van Kleij, managing director Netherlands Centre for Doping Affairs (NeCeDo).
  
       
11.30 - 12.15 “Perspective on Gene Doping of the World Anti-doping Agency (WADA)” by Olivier Rabin, science director WADA.  
       
12.15 - 13.00 “Gene Doping; an explanatory study into the risks and possibilities for prevention”
by Hidde Haisma, professor in gene modulation at the Groningen centre for Pharmacy and president of the Dutch society for Gene Therapy (NVGT).		  
     
13.00 - 14.00 Lunch    
       
       
14.30 - 15.15 “Gene transfer and athletics; an impeding problem” by prof. Theodore Friedmann, Department of Pediatrics, UCSD School of Medicine Program in Human Gene Therapy and Department of Pediatrics, La Jolla California.  
       
15.15 - 15.45 “The Athlete Perspective”by Carl Verheijen, international elite speed skater vice European Champion all-round and former world champion 10.000 meter.  
       
  Each lecture (except the introduction) includes 5-10 minutes of questions
   
       
     
 
 
 

The World Anti-doping Agency (WADA) promotes and coordinates, at the international level, the "fight" against doping in all its forms. To this end, WADA annually attributes research grants to teams performing activities within certain areas of priority.

As an example, 2003's research themes were:
- Compounds and/or methods enchancing oxygen delivery;
- Exogenous and edogenous anabolic steroids;
- Compounds and/or methods enhancing growth;
- Gene and cellular technologies applied to doping;
- Miscellaneous projects relating to the List of Prohibited Substances.

Candidates are invited to submit applications by May 14th, 2004 at the latest. The 2004 research priority areas, a specific application form and a list of additional documents to be provided are available on the Science and Medicine/Research section of WADA's website (http://www.wada-ama.org).
Further information can also be obtained from WADA's Research Manager, Dr Ann-Muriel Steff (e-mail: ann-muriel.steff@wada-ama.org).

All submitted projects falling within 2004 areas of priority will be peer reviewed by independent expert panels and ranked. Grants will be attributed on a merit basis. A response on the application can be expected by October 2004.
   
  Netherlands Centre for Doping Affairs (NeCeDo)
P.O. Box 5014, 2900 EA Capelle aan den IJssel, The Netherlands
tel.: + 31 (0)10 20 101 50, fax: + 31 (0)10 20 101 59,
website: www.necedo.nl
   
  World Anti-Doping Agency (WADA)
P.O. Box 120, Montreal (Quebec) H4Z 1B7, Canada
tel.: +1 514 904 9232, fax: +1 514 904 8650
website: www.wada-ama.org